Search results for "malignant"

showing 10 items of 283 documents

Incidence and profile of benign epithelial tumors of salivary glands from a single center in Northeast of Brazil

2020

Background Benign tumors of the salivary glands are a group of lesions with varied histopathological and clinical spectrum. The aim was to determine the incidence and clinicopathological characteristics of benign salivary gland neoplasms diagnosed between 2007 and 2016 in a single center located in northeastern Brazil. Material and Methods Records regarding sex, age, anatomical location, histopathological subtype and treatment were retrieved, and data were analyzed using the Stata/IC software (version 12.0). Results There were above 7,100 cases of neoplasms in the head and neck region, of which 403 corresponded to salivary gland neoplasms. Of these, 238 (59%) were benign, being pleomorphic …

AdultPathologymedicine.medical_specialtyAdolescentAdenomaSalivary GlandsMalignant transformationPleomorphic adenomaYoung Adult03 medical and health sciences0302 clinical medicineodonto-stomatological emergenciesCarcinomaspainHumansMedicineNeoplasmNeoplasms Glandular and EpithelialChildGeneral DentistryUNESCO:CIENCIAS MÉDICASAgedRetrospective StudiesAged 80 and overOral Medicine and PathologySalivary glandbusiness.industryResearchIncidenceIncidence (epidemiology)030206 dentistryMiddle AgedSalivary Gland Neoplasmsmedicine.diseaseParotid glandstomatognathic diseasesmedicine.anatomical_structureOtorhinolaryngologycovid-19FemaleSurgerybusinessBrazil
researchProduct

Expression of caveolin-1 in tooth germ, ameloblastoma and ameloblastic carcinoma

2020

Background The caveolin-1 protein (structural component of membrane caveolae) plays important roles in several biological functions, such as endocytosis, cell adhesion, and cell signaling. However, this protein has been associated with mechanisms of tumorigenesis in several neoplasms. The expression patterns and roles of caveolin-1 in the oral epithelium and in embryonic and odontogenic tumor tissues are still unclear. Material and Methods The expression of caveolin-1 was evaluated in samples of the normal gingival epithelium (n=7), human tooth germ (TG) (n=12), ameloblastoma (AM) (n=83), and ameloblastic carcinoma (AC) (n=9) by immunohistochemistry. Additionally, AM samples were analyzed b…

AdultPathologymedicine.medical_specialtyReal Time Polymerase Chain Reactionrecurrencegovernment.form_of_governmentCaveolin 1Odontogenic TumorsBiologymedicine.disease_causeAmeloblastic CarcinomaMalignant transformationAmeloblastomaWestern blotCaveolin-1medicineHumansCaveolina 1resectionAmeloblastomaGeneral DentistrycurettageUNESCO:CIENCIAS MÉDICASdesmoplastic ameloblastomaOral Medicine and Pathologymedicine.diagnostic_testResearchmixed radiopaque ? radiolucentCarcinomaOdontogenic tumorTooth Germmedicine.diseaseImmunohistochemistryAmeloblastic carcinomaOtorhinolaryngologyCaveolin 1governmentImmunohistochemistrySurgeryCarcinogenesisenucleationMedicina Oral, Patología Oral y Cirugía Bucal
researchProduct

Ovarian Endometrioid-like Yolk Sac Tumor Treated by Surgery Alone, with Recurrence at 12 Years

1999

Abstract We describe the case of a stage Ia endometrioid-like yolk sac tumor (YST) of the ovary, which was originally misdiagnosed as a malignant struma ovarii and not treated with adjuvant chemotherapy. After 12 years, a contralateral dermoid cyst was excised along with a small omental nodule of partially necrotic and calcified endometrioid-like YST. No tumor was detected in several other biopsy specimens, and a peritoneal lavage was negative for tumor cells. Since there was no evidence of remaining tumor and the serum α-fetoprotein (AFP) level was normal after the second operation, the patient was followed. Serial serum AFP levels remained normal for 4 months. At a second-look laparotomy …

AdultReoperationPathologymedicine.medical_specialtyTime Factorsmedicine.medical_treatmentOvaryLaparotomyBiopsyHumansMedicineYolk sacPeritoneal NeoplasmsOvarian Neoplasmsmedicine.diagnostic_testbusiness.industryEndodermal Sinus TumorObstetrics and GynecologyMalignant Struma Ovariimedicine.diseaseSurgerymedicine.anatomical_structureOncologyDermoid cystFemaleHistopathologyNeoplasm Recurrence LocalPouchbusinessOmentumGynecologic Oncology
researchProduct

Primary cutaneous lymphomas in children: A prospective study from the Spanish Academy of Dermatology and Venereology (AEDV) Primary Cutaneous Lymphom…

2021

Background/Objectives Primary cutaneous lymphomas are rare in pediatric patients. The clinical and histopathological manifestations may differ from those in adults. Due to their low frequency and the insidious clinical picture, the diagnosis is usually delayed. The Spanish Primary Cutaneous Lymphoma Registry was initiated in 2016 as a multicenter registry that would allow better insight into the epidemiological, clinical, histopathological, and treatment response characteristics of patients with primary cutaneous lymphomas. Methods We conducted a prospective observational cohort study of primary cutaneous lymphomas in pediatric patients participating in the Spanish Academy of Dermatology an…

AdultTreatment responsemedicine.medical_specialtyVenereologySkin NeoplasmsAdolescentlymphomaDermatologyMycosis FungoidesVenereologyEpidemiologymedicineneoplasms-malignantHumansProspective StudiesRegistriesProspective cohort studyChildtherapy-topicalMycosis fungoidesbusiness.industryPrimary cutaneous lymphomamedicine.diseaseDermatologyLymphomaPediatrics Perinatology and Child HealthbusinessphototherapyCohort studyPediatric dermatologyREFERENCES
researchProduct

(Partial) loss of BAF250a (ARID1A) in rectovaginal deep-infiltrating endometriosis, endometriomas and involved pelvic sentinel lymph nodes

2015

study hypothesis: Loss of protein BAF250a (ARID1A) expression is present in women with rectovaginal deep-infiltrating endometriosis (DIE) and endometriosis affecting the pelvic sentinel lymph nodes (PSLN). study finding: Partial loss of protein BAF250a was found in some of our patient samples, comprising all endometriosis entities, including rectovaginal DIE and endometriosis affecting the PSLN. what is known already: Loss of BAF250a (BRG-associated factor 250a)/ARIDIA (AT-rich interactive domain 1A) protein expression was identified among endometriosis-associated ovarian carcinomas and ovarian endometriosis, and this phenomenonwas described as a possible early event in the transformation o…

Adultmedicine.medical_specialtyBAF250a human proteinEmbryologyARID1APelvic sentinel lymph nodePopulationEndometriosisEndometriosisDeep-infiltrating endometriosiEndometriumGastroenterologyMalignant transformation03 medical and health sciencesEndometriumYoung Adult0302 clinical medicineGeneticInternal medicineGeneticsmedicinePTENHumanseducationMolecular BiologyCancerOvarian Neoplasmseducation.field_of_study030219 obstetrics & reproductive medicinebiologyCancerNuclear ProteinsObstetrics and GynecologyCell BiologyMiddle Agedmedicine.diseaseImmunohistochemistryARID1ADNA-Binding Proteinsmedicine.anatomical_structureReproductive Medicine030220 oncology & carcinogenesisOvarian Endometriosisbiology.proteinFemaleSentinel Lymph NodeTranscription FactorsDevelopmental Biology
researchProduct

Pulmonary artery sarcoma with angiosarcoma phenotype mimicking pleomorphic malignant fibrous histiocytoma: a case report

2012

Abstract Primary sarcomas of the major blood vessels can be classified based on location in relationship to the wall or by histologic type. Angiosarcomas are malignant neoplasms that arise from the endothelial lining of the blood vessels; those arising in the intimal compartment of pulmonary artery are rare. We report a case of pulmonary artery angiosarcoma in a 36-year old female with pulmonary masses. The patient had no other primary malignant neoplasm, thus excluding a metastatic lesion. Gross examination revealed a thickened right pulmonary artery and a necrotic and hemorrhagic tumor, filling and occluding the vascular lumen. The mass extended distally, within the pulmonary vasculature …

Adultmedicine.medical_specialtyPathologyHistologyBiopsyHemangiosarcomaCase ReportHistiocytoma Malignant FibrousPathology and Forensic MedicinePredictive Value of Testsmedicine.arteryVascular NeoplasmBiomarkers TumorAngiosarcomalcsh:PathologyMedicineHumansAngiosarcomaDiagnostic ErrorsPneumonectomyCell ProliferationPulmonary Artery AngiosarcomaLungbusiness.industrySarcomaGeneral Medicinemedicine.diseaseRight pulmonary arteryImmunohistochemistryVascular NeoplasmsPulmonary arteryHemangiosarcomamedicine.anatomical_structurePhenotypeTreatment OutcomeChemotherapy AdjuvantPulmonary arteryFemaleSarcomaRadiologybusinessTomography X-Ray Computedlcsh:RB1-214Diagnostic Pathology
researchProduct

Thymoma and pure red cell aplasia in a patient with systemic lupus erythematosus.

1995

We present the case of a female patient with a diagnosis of systemic lupus erythematosus (SLE) at the age of 54 years. At the age of 63 years, she suffered from malignant thymoma and 3 years after removal of the thymoma a diagnosis of pure red cell aplasia (PRCA) was established. This is, to our knowledge, the first report of the occurrence of SLE, thymoma and PRCA in the same patient. The case is discussed with regard to the already known associations between these diseases.

Adultmedicine.medical_specialtySystemic diseasePathologyThymomaThymomaImmunologyPure red cell aplasiaBone Marrow Aplasiaurologic and male genital diseasesRed-Cell Aplasia PureRheumatologyimmune system diseasesBone Marrowhemic and lymphatic diseasesmedicineImmunology and AllergyHumansLupus Erythematosus Systemicskin and connective tissue diseasesMalignant ThymomaLupus erythematosusThymus Neoplasmbusiness.industryGeneral MedicineThymus Neoplasmsmedicine.diseaseConnective tissue diseaseDermatologyFemalebusinessScandinavian journal of rheumatology
researchProduct

Abstract 2903: IMAB362, a novel first-in-class monoclonal antibody for treatment of pancreatic cancer

2014

Abstract Pancreatic ductal adenocarcinoma (PDAC), the most frequent subtype (>80%) of pancreatic cancer (PC) is characterized by a generally lethal progress within a short period of time after primary diagnosis. Despite high efforts, the treatment options are very limited and mainly of palliative nature. Therefore, we investigated whether IMAB362 might represent a potential treatment option in this patient population. IMAB362 is a highly potent and tumor-cell selective therapeutic antibody which is currently in clinical development in gastro-esophageal cancer (in phase II and IIb trials). IMAB362 is directed against the tight junction molecule CLDN18.2, a proliferation-promoting tran…

Antibody-dependent cell-mediated cytotoxicityCancer Researchbusiness.industrymedicine.drug_classCancermedicine.diseaseMonoclonal antibodyGemcitabineMalignant transformationOncologyIn vivoPancreatic cancerImmunologymedicineCancer researchbusinessIMAB362medicine.drugCancer Research
researchProduct

Multicentre evaluation of in vitro contracture testing with bolus administration of 4-chloro-m-cresol for diagnosis of malignant hyperthermia suscept…

2003

Background and objective The in vitro contracture test with halothane and caffeine is the gold standard for the diagnosis of susceptibility to malignant hyperthermia (MH). However, the sensitivity of the in vitro contracture test is between 97 and 99% and its specificity is 78-94% with the consequence that false-negative as well as false-positive test results are possible. 4-Chloro-m-cresol is potentially a more specific test drug for the in vitro contracture test than halothane or caffeine. This multicentre study was designed to investigate whether an in vitro contracture test with bolus administration of 4-chloro-m-cresol can improve the accuracy of the diagnosis of susceptibility to MH. …

BiopsyIn Vitro TechniquesSensitivity and SpecificityCresolsCaffeineBiopsymedicineHumansMuscle SkeletalMuscle contracturemedicine.diagnostic_testInhalationbusiness.industryMalignant hyperthermiaGold standard (test)medicine.diseaseAnesthesiology and Pain MedicineAnesthesiaDisease SusceptibilityHuman medicineContracturemedicine.symptomHalothaneComplicationbusinessHalothaneMalignant Hyperthermiamedicine.drugMuscle ContractionEuropean Journal of Anaesthesiology
researchProduct

Prospective Study of the Evolution of Blood Lymphoid Immune Parameters during Dacarbazine Chemotherapy in Metastatic and Locally Advanced Melanoma Pa…

2014

BackgroundThe importance of immune responses in the control of melanoma growth is well known. However, the implication of these antitumor immune responses in the efficacy of dacarbazine, a cytotoxic drug classically used in the treatment of melanoma, remains poorly understood in humans.MethodsIn this prospective observational study, we performed an immunomonitoring of eleven metastatic or locally advanced patients treated with dacarbazine as a first line of treatment. We assessed by flow cytometry lymphoid populations and their activation state; we also isolated NK cells to perform in vitro cytotoxicity tests.ResultsWe found that chemotherapy induces lymphopenia and that a significantly hig…

CD4-Positive T-LymphocytesMaleSkin Neoplasmsmedicine.medical_treatmentCancer TreatmentGene ExpressionNK cellsLymphocyte ActivationT-Lymphocytes RegulatoryLeukocyte CountCellular typesMedicine and Health SciencesCytotoxic T cellProspective StudiesNeoplasm MetastasisProspective cohort studyImmune ResponseMelanomaAged 80 and overMultidisciplinarymedicine.diagnostic_testReverse Transcriptase Polymerase Chain ReactionMelanomaQRMiddle AgedFlow CytometryPrognosis3. Good healthDacarbazineKiller Cells NaturalTreatment OutcomeOncologyCutaneous MelanomaMedicineWhite blood cellsFemaleImmunotherapymedicine.drugResearch ArticleTumor ImmunologyAdultCell biologyBlood cellsCell SurvivalDacarbazineScienceImmune CellsImmunologyLocally advancedT cellsMalignant Skin NeoplasmsDermatologyCancer ImmunotherapyFlow cytometryImmune systemCell Line TumormedicineHumansAntineoplastic Agents AlkylatingAgedChemotherapyBiology and life sciencesbusiness.industrymedicine.diseaseAnimal cellsImmunologyCancer researchClinical ImmunologybusinessTranscription FactorsPLoS ONE
researchProduct